Recent Progress in the Treatment of Pulmonary Arterial Hypertension: Expectation for Rho-Kinase Inhibitors
Author:
Affiliation:
1. Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
2. Technology Agency, CREST
Publisher
Tohoku University Medical Press
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Link
http://www.jstage.jst.go.jp/article/tjem/211/4/211_4_309/_pdf
Reference68 articles.
1. Long-Term Treatment With a Rho-Kinase Inhibitor Improves Monocrotaline-Induced Fatal Pulmonary Hypertension in Rats
2. Prostacyclin Does Not Inhibit Rho-Kinase
3. Long-Term Inhibition of Rho-kinase Ameliorates Hypoxia-Induced Pulmonary Hypertension in Mice
4. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
5. Diagnosis and differential assessment of pulmonary arterial hypertension
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pulmonary arterial hypertension nanotherapeutics: New pharmacological targets and drug delivery strategies;Journal of Controlled Release;2024-01
2. Rho/Rho Kinase Signaling Pathway and Disease: from Bed to Bench;Frontiers in Cardiovascular Drug Discovery;2022-11-09
3. PDGF mediates pulmonary arterial smooth muscle cell proliferation and migration by regulating NFATc2;Molecular Medicine Reports;2020-11-10
4. Gene expression profile in persistent pulmonary hypertension of newborn, preliminary report;J PEDIATR NEONATAL I;2020
5. Principles of pharmacological correction of pulmonary arterial hypertension;Research Results in Pharmacology;2018-08-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3